Results 11 to 20 of about 37,334 (230)
The effect of cardiac resynchronization on morbidity and mortality in heart failure [PDF]
Background: Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony.
Cleland, John G.F. +6 more
core +3 more sources
Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy.
Teruhiko Imamura
doaj +1 more source
Overview of Current Strategies Aiming at Improving Response to Cardiac Resynchronization Therapy
Cardiac resynchronization therapy is a treatment modality developed in the early 2000s that targets the mechanical and electrical dyssynchrony in heart failure with reduced ejection fraction patients. Appropriate patient selection conditions specified in
Yakup Yunus Yamantürk +3 more
doaj +1 more source
The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation [PDF]
Cardiac resynchronization therapy (CRT) is a disease-modifying therapy in patients with chronic heart failure (CHF). Current guidelines ascribe CRT eligibility on three parameters only: left ventricular ejection fraction (LVEF), QRS duration, and New ...
de Groot, J R +7 more
core +1 more source
Cardiac resynchronization therapy [PDF]
The first case report introducing the concept of cardiac resynchronisation therapy (CRT) was published less than 10 years ago, opening the way to the development of the first successful non-pharmacological treatment of congestive heart failure (CHF).
S, Cazeau +4 more
openaire +2 more sources
Cardiac resynchronization therapy
It is now well established that electrical and mechanical dyssynchrony are not clinically synonymous; however, at present no individual noninvasive method can reliably and consistently identify the criteria for mechanical dysfunction correctable through device therapy. The results of the PROSPECT (Predictors of Response to CRT) trial not only highlight
Daniel M, Couri, Sunil, Mankad
+6 more sources
Background: Cardiovascular disease remains the leading cause of death in the European Union and worldwide. Constant improvement in cardiac care is leading to an increased number of patients with heart failure, which is a challenging condition in terms of
Bartosz Krzowski +7 more
doaj +1 more source
Cardiac Resynchronization Therapy
Congestive heart failure (CHF) has become a major health problem. Despite improved pharmacologic therapies, refractory symptoms and high mortality remain a challenge in such patients. There has been increased interest in the application of ancillary nonpharmacologic therapies for CHF management, such as implantable pacemakers, defibrillators, and/or ...
Cleland, John G.F. +4 more
+5 more sources
Superresponse to Cardiac Resynchronization Therapy [PDF]
Case presentation : A 55-year-old female patient underwent implantation of a cardiac resynchronization therapy (CRT) defibrillator 6 years ago owing to nonischemic dilated cardiomyopathy. Her left-ventricular (LV) ejection fraction (EF) was 28% before implantation, her LV end-diastolic volume index (EDVI) was 144 mL/m2, and her LV end-systolic volume ...
Steffel, Jan, Ruschitzka, Frank
openaire +3 more sources
Background Cardiac resynchronization therapy has been shown to benefit selected patients with heart failure and reduced ejection fraction. Older patients have been underrepresented in randomized trials.
Laure Champ-Rigot +6 more
doaj +1 more source

